During the past decade, Wilhelm- Anton- Hospital gGmbH conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 2 clinical trials were completed, i.e. on average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 1 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Wilhelm- Anton- Hospital gGmbH" #1 sponsor was "University of Ulm" with 12 trials, followed by "German High-Grade Non-Hodgkin's Lymphoma Study Group" with 2 trials sponsored, "Stichting Hemato-Oncologie voor Volwassenen Nederland" with 2 trials sponsored, "Heinrich-Heine University, Duesseldorf" with 1 trials sponsored and "Hoffmann-La Roche" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Wilhelm- Anton- Hospital gGmbH" #1 collaborator was "Deutsch-Österreichische Studiengruppe Akute Myeloische Leukämie (AMLSG)" with 2 trials as a collaborator, "Astellas Pharma Global Development, Inc." with 1 trials as a collaborator, "German Federal Ministry of Education and Research" with 1 trials as a collaborator and "Novartis Pharmaceuticals" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Wilhelm- Anton- Hospital gGmbH" are "Acute Myeloid Leukemia" (7 trials), "Acute Myeloid Leukemia (AML)" (6 trials), "Lymphoma" (2 trials), "Metastatic Breast Cancer" (2 trials) and "Myelodysplastic Syndrome With Excess Blasts-2" (2 trials). Many other conditions were trialed in "Wilhelm- Anton- Hospital gGmbH" in a lesser frequency.

Most popular intervention types in "Wilhelm- Anton- Hospital gGmbH" are "Drug" (19 trials), "Biological" (3 trials), "Radiation" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cytarabine" (9 trials), "Idarubicin" (4 trials), "Daunorubicin" (3 trials), "Etoposide" (3 trials) and "Mitoxantrone" (3 trials). Other intervention names were less common.

The vast majority of trials in "Wilhelm- Anton- Hospital gGmbH" are 19 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Wilhelm- Anton- Hospital gGmbH". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Wilhelm- Anton- Hospital gGmbH, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Wilhelm- Anton- Hospital gGmbH, 1 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".